Biomarkers of Benzene Exposure and Genotoxicity

苯暴露和遗传毒性的生物标志物

基本信息

  • 批准号:
    6780512
  • 负责人:
  • 金额:
    $ 35.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1993
  • 资助国家:
    美国
  • 起止时间:
    1993-08-01 至 2008-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The shape of the dose-response curve for benzene-induced leukemia at exposures below 10 ppm is a key public policy and risk assessment issue involving potentially billions of dollars. During the previous grant period, biological samples were collected from 250 workers exposed to a wide range of benzene concentrations (0.2 to 50 ppm as a time-weighted average, with 88% of the workers being exposed to <10 ppm) and 140 matched controls. These biological samples will be analyzed using a biomarker approach to (a) shed light on the dose-response curve for benzene's hematotoxic and genotoxic effects between 0.2 and 50 ppm in air and its mechanisms of toxicity; and, (b) develop new biomarkers of exposure, early effect and susceptibility for benzene. Leukemia-specific chromosome aberrations will be measured by fluorescence in situ hybridization in the metaphase spreads of lymphocytes of all 390 study subjects and the dose-response relationship evaluated. Further, using a new technique called OctoChrome FISH the effects of benzene on all chromosomes will be investigated to determine if it has selective effects. In a sub-group of 53 subjects hematopoietic progenitor cells circulating in the blood were cultured in colony forming assays, allowing us to evaluate the dose-dependent effects of benzene on these target cells. The level of genetic damage in progenitor cells will also be compared with that found in lymphocytes to determine if the latter are good surrogates. More than 40 genetic polymorphisms and folate and vitamin B status have been determined in all study subjects. This data will be correlated with data on chromosome damage and hematotoxicity to determine the role these effect-modifiers play in susceptibility to benzene. Finally, emerging technologies, such as microarrays and proteomics, offer a significant opportunity to develop new biomarkers and provide key mechanistic information. The use of Affymetrix microarrays is proposed and will reveal changes in gene expression related to benzene exposure. Further, application of a Ciphergen ProteinChip mass spectrometer will allow for differentially expressed proteins and protein modifications related to benzene exposure to be identified and a protein profile for benzene exposure to be established in serum and lymphocytes. The overall goal is to develop new biomarkers of exposure and early effect for benzene and provide new insights into the mechanisms of benzene toxicity.
描述(由申请人提供):暴露在10ppm以下的苯引起的白血病的剂量-反应曲线的形状是一个关键的公共政策和风险评估问题,可能涉及数十亿美元。在前一次赠款期间,从250名暴露于大范围苯浓度(按时间加权平均为0.2至50ppm,88%的工人暴露于10ppm)的工人和140名匹配的对照组中收集了生物样本。这些生物样本将使用生物标记物方法进行分析,以(A)阐明空气中0.2至50ppm的苯的血液毒性和遗传毒性效应的剂量-反应曲线及其毒性机制;以及(B)开发苯的暴露、早期影响和敏感性的新生物标记物。我们将用荧光原位杂交技术在所有390名研究对象的淋巴细胞中期铺展中测量白血病特异的染色体畸变率,并评估剂量-反应关系。此外,使用一种名为OcChrome FISH的新技术,将研究苯对所有染色体的影响,以确定它是否具有选择性作用。在53名受试者的子组中,血液中循环的造血祖细胞在集落形成试验中进行培养,使我们能够评估苯对这些靶细胞的剂量依赖效应。祖细胞的遗传损伤水平也将与淋巴细胞中发现的水平进行比较,以确定后者是否是良好的替代品。在所有研究对象中,已经确定了40多个基因多态和叶酸和维生素B状态。这些数据将与染色体损伤和血液毒性数据相关联,以确定这些效应修饰物在苯易感性中所起的作用。最后,新兴技术,如微阵列和蛋白质组学,为开发新的生物标记物和提供关键的机制信息提供了重要的机会。建议使用Affymetrix微阵列,并将揭示与苯接触相关的基因表达的变化。此外,Ciphergen蛋白质芯片质谱仪的应用将允许识别与苯接触有关的差异表达蛋白质和蛋白质修饰,并建立血清和淋巴细胞中苯接触的蛋白质图谱。总体目标是开发苯暴露和早期影响的新生物标记物,并为苯毒性的机制提供新的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARTYN T SMITH其他文献

MARTYN T SMITH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARTYN T SMITH', 18)}}的其他基金

Project 3: Arsenic Biomarker Epidemiology
项目3:砷生物标志物流行病学
  • 批准号:
    8889475
  • 财政年份:
    2014
  • 资助金额:
    $ 35.81万
  • 项目类别:
Toxic Substances in the Environment
环境中的有毒物质
  • 批准号:
    7916285
  • 财政年份:
    2009
  • 资助金额:
    $ 35.81万
  • 项目类别:
Toxic Substances in the Environment
环境中的有毒物质
  • 批准号:
    7918623
  • 财政年份:
    2009
  • 资助金额:
    $ 35.81万
  • 项目类别:
Toxic Substances in the Environment
环境中的有毒物质
  • 批准号:
    7916287
  • 财政年份:
    2009
  • 资助金额:
    $ 35.81万
  • 项目类别:
HEALTH EFFECTS OF TOXIC SUBSTANCES
有毒物质对健康的影响
  • 批准号:
    7358992
  • 财政年份:
    2006
  • 资助金额:
    $ 35.81万
  • 项目类别:
Adminstrative Core
行政核心
  • 批准号:
    7089431
  • 财政年份:
    2006
  • 资助金额:
    $ 35.81万
  • 项目类别:
HEALTH EFFECTS OF TOXIC SUBSTANCES
有毒物质对健康的影响
  • 批准号:
    7183222
  • 财政年份:
    2005
  • 资助金额:
    $ 35.81万
  • 项目类别:
HEALTH EFFECTS OF TOXIC SUBSTANCES
有毒物质对健康的影响
  • 批准号:
    6975549
  • 财政年份:
    2004
  • 资助金额:
    $ 35.81万
  • 项目类别:
Genetic Susceptibility to Non-Hodgkins Lymphoma
非霍奇金淋巴瘤的遗传易感性
  • 批准号:
    7123953
  • 财政年份:
    2003
  • 资助金额:
    $ 35.81万
  • 项目类别:
Genetic Susceptibility to Non-Hodgkins Lymphoma
非霍奇金淋巴瘤的遗传易感性
  • 批准号:
    6806520
  • 财政年份:
    2003
  • 资助金额:
    $ 35.81万
  • 项目类别:

相似海外基金

Greatwall in replication stress/DNA damage responses and oral cancer resistance
长城在复制应激/DNA损伤反应和口腔癌抵抗中的作用
  • 批准号:
    10991546
  • 财政年份:
    2024
  • 资助金额:
    $ 35.81万
  • 项目类别:
The shielding role of the nuclear periphery against the genetic and non-genetic consequences of DNA damage (ChromoSENSOR)
核外围对 DNA 损伤的遗传和非遗传后果的屏蔽作用 (ChromoSENSOR)
  • 批准号:
    EP/Y027124/1
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
    Research Grant
Aspartate beta-hydroxylase and DNA damage in chronic liver diseases
慢性肝病中的天冬氨酸 β-羟化酶和 DNA 损伤
  • 批准号:
    10667881
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
Role of DNA damage and cellular senescence in osteoarthritis pathophysiology
DNA 损伤和细胞衰老在骨关节炎病理生理学中的作用
  • 批准号:
    10801026
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability
ATR 在跨损伤合成中的作用对预防 DNA 损伤诱导的突变和染色体不稳定性的影响
  • 批准号:
    10634852
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
The interface of transcription, DNA damage and epigenetics: A therapeutic vulnerability of the EWS-FLI1 transcription factor
转录、DNA 损伤和表观遗传学的界面:EWS-FLI1 转录因子的治疗脆弱性
  • 批准号:
    10718793
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
  • 批准号:
    10747651
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
Targeting the function of BRCA1 in the DNA damage response network.
靶向 DNA 损伤反应网络中 BRCA1 的功能。
  • 批准号:
    2879783
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
    Studentship
Elucidation of the mechanism underlying cellular senescence and aging induced by the continuous DNA damage
阐明持续DNA损伤引起的细胞衰老和老化的机制
  • 批准号:
    22KJ0646
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma
TAZ 和 YAP 在 3D 基因组组织 DNA 损伤修复中的新作用以及胶质母细胞瘤的治疗耐药性
  • 批准号:
    10649830
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了